<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vtio</journal-id><journal-title-group><journal-title xml:lang="ru">Вестник трансплантологии и искусственных органов</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Transplantology and Artificial Organs</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-1191</issn><publisher><publisher-name>Academician V.I.Shumakov National Medical Research Center of Transplantology and Artificial Organs", Ministry of Health of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15825/1995-1191-2015-2-51-59</article-id><article-id custom-type="elpub" pub-id-type="custom">vtio-549</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Трансплантация сердца и вспомогательное кровообращение</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Heart Transplantation and Assisted Circulation</subject></subj-group></article-categories><title-group><article-title>СОЧЕТАННАЯ ПЛАЗМОФИЛЬТРАЦИЯ, СЕЛЕКТИВНАЯ АДСОРБЦИЯ ЦИТОКИНОВ С ГЕМОФИЛЬТРАЦИЕЙ И ПЛАЗМООБМЕН В КОРРЕКЦИИ ТРОМБОЦИТАРНО-КОАГУЛЯЦИОННОГО ГЕМОСТАЗА ПРИ СИНДРОМЕ ДИССЕМИНИРОВАННОГО ВНУТРИСОСУДИСТОГО СВЕРТЫВАНИЯ</article-title><trans-title-group xml:lang="en"><trans-title>COMBINED PLASMA FILTRATION, SELECTIVE ADSORPTION OF CYTOKINES WITH HEMOFILTRATION AND PLASMA EXCHANGE IN THE CORRECTION OF PLATELET AND COAGULATION HEMOSTASIS IN PATIENTS WITH THE SYNDROME OF DISSEMINATED INTRAVASCULAR COAGULATION</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бельских</surname><given-names>Л. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Belskikh</surname><given-names>L. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Для корреспонденции: Бельских Леонид Владиславович. Адрес:101000, г. Москва, Чистопрудный бульвар, д. 13, стр. 3. Тел. (980) 340-15-45. E-mail: belskihl@mail.ru.</p></bio><bio xml:lang="en"><p>For correspondence: Belskikh Leonid Vladislavovich. Address: 13/3, Chistoprudny boul., Moscow 101000, Russian Federation. Tel. (980) 340-15-45. E-mail: belskihl@mail.ru</p></bio><email xlink:type="simple">belskihl@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зулькарнаев</surname><given-names>А. Б.</given-names></name><name name-style="western" xml:lang="en"><surname>Zulkarnaev</surname><given-names>A. B.</given-names></name></name-alternatives><email xlink:type="simple">belskihl@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Василенко</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vasilenko</surname><given-names>I. A.</given-names></name></name-alternatives><email xlink:type="simple">belskihl@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ватазин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Vatazin</surname><given-names>A. V.</given-names></name></name-alternatives><email xlink:type="simple">belskihl@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского</institution><country>Россия</country></aff><aff xml:lang="en"><institution>M.F. Vladimirsky Moscow Regional Research and Clinical Institute, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Российский национальный исследовательский медицинский университет имени Н.И. Пирогова, г. Москва</institution><country>Россия</country></aff><aff xml:lang="en"><institution>N.I. Pirogov Russian National Research Medical University, Moscow</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2015</year></pub-date><pub-date pub-type="epub"><day>26</day><month>05</month><year>2015</year></pub-date><volume>17</volume><issue>2</issue><fpage>51</fpage><lpage>59</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Бельских Л.В., Зулькарнаев А.Б., Василенко И.А., Ватазин А.В., 2015</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="ru">Бельских Л.В., Зулькарнаев А.Б., Василенко И.А., Ватазин А.В.</copyright-holder><copyright-holder xml:lang="en">Belskikh L.V., Zulkarnaev A.B., Vasilenko I.A., Vatazin A.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.transpl.ru/vtio/article/view/549">https://journal.transpl.ru/vtio/article/view/549</self-uri><abstract/><trans-abstract xml:lang="en"><p>Aim. To improve the efficiency of treatment of the patients with pancreatic necrosis through correcting the platelet-coagulation potential by methods of combined plasma filtration, selective sorption of cytokines with hemofiltration and plasmapheresis. Methods. The effects of selective sorption of cytokines with hemofiltration and plasmapheresis upon coagulation potential were studied in 70 patients with acute pancreatitis. Plasmapheresis was performed on PCS 2 (Haemonetics, USA); selective sorption of cytokines with hemofiltration – on Lynda ® machine (Bellco, Italy). The method of computer laser phasemeter was used for vital assessing of platelet morphofunctional status. Results. In patients with pancreatic necrosis in the fermentation phase the percentage of resting platelets was 51.3%, which is 12% below the control numbers. The number of activated platelets increased: 25.1% of the cells were represented by platelets with low activation; 15.5% – highly activated cells. The number of degenerative-modified platelets increased by two times – up to 8.1%. In the phase of sequestration and suppurative complications the percentage of resting platelets was only 42.3%, which is 1.5 times lower than the control numbers. 34.2% of the cells were presented by platelets with low activation; 11.0% – highly activated cells. The number of degenerative-modified platelets exceeded 12.5%. The analysis of the morphological structure of the platelets population revealed that due to plasmapheresis inclusion into therapeutic complex in the phase of intoxication of pancreatic necrosis the normalization of platelet activation status of hemostasis was observed. In 5 (20%) patients the normalization of average platelets morphometric parameters was shown after selective sorption of cytokines with hemofiltration and plasmapheresis. These patients demonstrated positive clinical dynamics. In 15 patients morphometric values of platelets either remained at the same value or continued to increase progressively. In this subgroup of the patients purulent complications progressed in 9 patients, mortality was 35%. Conclusion. Thus, the level of thrombocyte hemostasis in different phases of pancreatic necrosis can be quantified using indicators of morphofunctional status of circulating platelets. When dealing with coagulation version of disseminated intravascular coagulation syndrome the number of activated cells is on the rise up to 40% or more. The development of consumption coagulopathy is characterized with progressive increase of degenerative platelets up to 10% or more. Combined plasma filtration, selective adsorption of cytokines with hemofiltration and exchange plasmapheresis are effective methods for adjusting of platelet and coagulation hemostasis in patients with necrotizing pancreatitis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром диссеминированного внутрисосудистого свертывания</kwd><kwd>тромбоциты</kwd><kwd>сочетанная плазмофильтрация и адсорбция (СПФА)</kwd><kwd>плазмообмен</kwd></kwd-group><kwd-group xml:lang="en"><kwd>disseminated intravascular coagulation</kwd><kwd>platelets</kwd><kwd>plasma fi ltration and concomitant adsorption</kwd><kwd>plasma exchange</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Баркаган ЗС, Момот АП. Современные аспекты патогенеза, диагностики и терапии ДВС-синдрома. Вестник гематологии. 2005; 1 (2): 5–14. Barkagan ZS, Momot AP. Sovremennye aspekty patogeneza, diagnostiki i terapii DVS-sindroma. Vestnik gematologii. 2005; 1 (2): 5–14.</mixed-citation><mixed-citation xml:lang="en">Баркаган ЗС, Момот АП. Современные аспекты патогенеза, диагностики и терапии ДВС-синдрома. Вестник гематологии. 2005; 1 (2): 5–14. Barkagan ZS, Momot AP. Sovremennye aspekty patogeneza, diagnostiki i terapii DVS-sindroma. Vestnik gematologii. 2005; 1 (2): 5–14.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Баркаган ЗС. Современные аспекты патогенеза и терапии острого ДВС-синдрома / З.С. Баркаган, А.П. Момот, Л.П. Цывкина. Сибирский консилиум. 2004; 35 (6): 35−39. Barkagan ZS. Sovremennye aspekty patogeneza i terapii ostrogo DVS-sindroma / Z.S. Barkagan, A.P. Momot, L.P. Cyvkina. Sibirskij konsilium. 2004; 35 (6): 35−39.</mixed-citation><mixed-citation xml:lang="en">Баркаган ЗС. Современные аспекты патогенеза и терапии острого ДВС-синдрома / З.С. Баркаган, А.П. Момот, Л.П. Цывкина. Сибирский консилиум. 2004; 35 (6): 35−39. Barkagan ZS. Sovremennye aspekty patogeneza i terapii ostrogo DVS-sindroma / Z.S. Barkagan, A.P. Momot, L.P. Cyvkina. Sibirskij konsilium. 2004; 35 (6): 35−39.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Симбирцев АС. Цитокины – новая система регуляции защитных реакций организма. Цитокины и воспаление. 2002; 1: 9–16. Simbircev AS. Citokiny – novaya sistema regulyacii zashchitnyh reakcij organizma. Citokiny i vospalenie. 2002; 1: 9–16.</mixed-citation><mixed-citation xml:lang="en">Симбирцев АС. Цитокины – новая система регуляции защитных реакций организма. Цитокины и воспаление. 2002; 1: 9–16. Simbircev AS. Citokiny – novaya sistema regulyacii zashchitnyh reakcij organizma. Citokiny i vospalenie. 2002; 1: 9–16.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bone RC. Sepsis: a new hypothesis for pathogenesis of the disease process / R.C. Bone, C.J. Grodzin, R.A. Balk. Chest. 1997; 1 (12): 235–243.</mixed-citation><mixed-citation xml:lang="en">Bone RC. Sepsis: a new hypothesis for pathogenesis of the disease process / R.C. Bone, C.J. Grodzin, R.A. Balk. Chest. 1997; 1 (12): 235–243.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chong DL. Pro-inflammatory mechanisms in sepsis / D.L. Chong, S. Sriskandan. Contrib Microbiol. 2011; 17: 86–107.</mixed-citation><mixed-citation xml:lang="en">Chong DL. Pro-inflammatory mechanisms in sepsis / D.L. Chong, S. Sriskandan. Contrib Microbiol. 2011; 17: 86–107.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">DiLeo MV. A simple mathematical model of cytokine capture using a hemoadsorption device / M.V. DiLeo, J.A. Kellum, W.J. Federspiel. Ann Biomed Eng. 2009; 1 (37): 222–229.</mixed-citation><mixed-citation xml:lang="en">DiLeo MV. A simple mathematical model of cytokine capture using a hemoadsorption device / M.V. DiLeo, J.A. Kellum, W.J. Federspiel. Ann Biomed Eng. 2009; 1 (37): 222–229.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Formica M. Coupled plasma filtration adsorption / M. Formica [et al.]. Contrib Nephrol. 2007; 156: 405–410.</mixed-citation><mixed-citation xml:lang="en">Formica M. Coupled plasma filtration adsorption / M. Formica [et al.]. Contrib Nephrol. 2007; 156: 405–410.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kitchens CS, Alving BM, Kessler CM. Consultative Hemostasis and Thrombosis. W.B. Saunders Company. 2004: 342.</mixed-citation><mixed-citation xml:lang="en">Kitchens CS, Alving BM, Kessler CM. Consultative Hemostasis and Thrombosis. W.B. Saunders Company. 2004: 342.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Critical Care Medicine. 2001; 29 (7): 90–94.</mixed-citation><mixed-citation xml:lang="en">Levi M, de Jonge E, van der Poll T. Rationale for restoration of physiological anticoagulant pathways in patients with sepsis and disseminated intravascular coagulation. Critical Care Medicine. 2001; 29 (7): 90–94.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mao HJ. Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome / H.J. Mao [et al.]. Int. J. Artif. Organs. 2009; 1 (32): 31–38.</mixed-citation><mixed-citation xml:lang="en">Mao HJ. Effects of coupled plasma filtration adsorption on immune function of patients with multiple organ dysfunction syndrome / H.J. Mao [et al.]. Int. J. Artif. Organs. 2009; 1 (32): 31–38.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Osuchowski MF. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality / M.F. Osuchowski [et al.]. J. Immunol. 2006; 3 (177): 1967–1974.</mixed-citation><mixed-citation xml:lang="en">Osuchowski MF. Circulating cytokine/inhibitor profiles reshape the understanding of the SIRS/CARS continuum in sepsis and predict mortality / M.F. Osuchowski [et al.]. J. Immunol. 2006; 3 (177): 1967–1974.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Shubin NJ. Anti-inflammatory mechanisms of sepsis / N.J. Shubin, S.F. Monaghan, A. Ayala. Contrib. Microbiol. 2011; 17: 108–124.</mixed-citation><mixed-citation xml:lang="en">Shubin NJ. Anti-inflammatory mechanisms of sepsis / N.J. Shubin, S.F. Monaghan, A. Ayala. Contrib. Microbiol. 2011; 17: 108–124.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Taniguchi T. Cytokine adsorbing columns / T. Taniguchi. Contrib. Nephrol. 2010; 166: 134–141.</mixed-citation><mixed-citation xml:lang="en">Taniguchi T. Cytokine adsorbing columns / T. Taniguchi. Contrib. Nephrol. 2010; 166: 134–141.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Thomson AW, Lotze MT. The Cytokine Handbook. London, San Diego: Academic Press, 2003: 273.</mixed-citation><mixed-citation xml:lang="en">Thomson AW, Lotze MT. The Cytokine Handbook. London, San Diego: Academic Press, 2003: 273.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets / W.J. Wiersinga. Curr Opin Crit Care. 2011; 5 (17): 480–486.</mixed-citation><mixed-citation xml:lang="en">Wiersinga WJ. Current insights in sepsis: from pathogenesis to new treatment targets / W.J. Wiersinga. Curr Opin Crit Care. 2011; 5 (17): 480–486.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
